Obama's budget shortens biologic exclusivity, cuts drug spending

04/11/2013 | Medical Marketing & Media · In-PharmaTechnologist.com

President Barack Obama's budget proposal would reduce biologic exclusivity from 12 years to seven, and it includes more than $160 billion in reduced spending that affects drugmakers. The plan would increase discounts for branded medications under Medicare Part D and reduce prices for drugs for people eligible for both Medicare and Medicaid.

View Full Article in:

Medical Marketing & Media · In-PharmaTechnologist.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC